Captor Therapeutics SA vs Cullgen Inc.
Captor Therapeutics SA
Captor Therapeutics aims to treat cancer, infections, and diseases by targeting the difficult-to-drug proteome
85 employees · est. 2017 · Poland
Cullgen Inc.
Powering protein degradation for tomorrow's medicines
27 employees · est. 2018 · San Diego, United States
Captor Therapeutics SA is the older company (2017 vs 2018); Captor Therapeutics SA is the larger of the two.
Side-by-Side Comparison
| Metric | Captor Therapeutics SA | Cullgen Inc. |
|---|---|---|
| Founded | ||
| Founded | 2017 older | 2018 |
| Headquarters | ||
| Headquarters | Poland | San Diego, United States |
| Employees | ||
| Employees | 85 larger | 27 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Pharmaceutical | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | IPO | Acquired |
| Total Funding | ||
| Total Funding | $68.50M | $406.00M |
| Funding Rounds | ||
| Funding Rounds | 3 | 5 |
| Services | ||
| Services | Drug discovery using Targeted Protein Degradation (TPD) technology, Development of therapeutics for cancer and autoimmune diseases, Structure-guided optimization of lead compounds | Development of protein degraders, Research in novel E3 ligands, Non-opioid pain treatment solutions, Biopharmaceutical pipeline development |
| Target Customers | ||
| Target Customers | Healthcare providers, Pharmaceutical companies, Patients with severe conditions like cancer and autoimmune diseases, Research institutions | Pharmaceutical industry, Biotech researchers, Healthcare providers, Patients with debilitating diseases |
| Taxonomy | ||
| Taxonomy | Targeted Protein DegradationDrug DiscoveryCancer TreatmentAutoimmune Disease TreatmentNeurodegenerative Disease TreatmentProteome Targeting +7 | BiopharmaceuticalProtein Degradation TechnologyUSMITE™E3 LigandsDrug DiscoveryCancer Treatment +9 |
| Website | ||
| Website | captortherapeutics.com | cullgen.com |
About Captor Therapeutics SA
Captor Therapeutics SA is a pioneering company in the Biopharma, Biotechnology, and Pharmaceutical industries, headquartered in Poland. Founded in 2017, the company is publicly listed on the Warsaw Stock Exchange under the ticker WSE:CTX. Captor Therapeutics focuses on advancing drug discovery and...
About Cullgen Inc.
Cullgen Inc., founded in 2018, is at the forefront of the biopharmaceutical sector with its pioneering slogan: "Powering protein degradation for tomorrow's medicines." The company is headquartered in the United States and operates in the Biotechnology and Pharmaceutical industries. Leveraging its p...
Also comparing in this category
Comparing more than these two?
Get Captor Therapeutics SA, Cullgen Inc. and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Captor Therapeutics SA compare?
A PDF of Captor Therapeutics SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Captor Therapeutics SA with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Captor Therapeutics SA on 15 Jun 2026, and Cullgen Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
